Fidelity Investments’s Microbot Medical MBOT Stock Holding History

Fidelity Investments’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10	Buy	4 +3	+300%	+$7	﹤0.01%	5377
2025 Q4	$2	Sell	1 -310	-100%	-$734	﹤0.01%	5403
2025 Q3	$948	Buy	311 +310	+31,000%	+$967	﹤0.01%	5025
2025 Q2	$3	Sell	1 -6	-86%	-$14	﹤0.01%	5302
2025 Q1	$11	Buy	7 +6	+600%	+$11	﹤0.01%	5246
2024 Q4	$1	Buy	+1	New	+$1	﹤0.01%	5514
2024 Q3	–	Sell	-7	Closed	-$7	–	5642
2024 Q2	$7	Buy	+7	New	+$7	﹤0.01%	5306
2023 Q1	–	Sell	-1	Closed	-$3	–	5427
2022 Q4	$3	Buy	+1	New	+$4	﹤0.01%	5308
2022 Q2	–	Sell	-1	Closed	–	–	5263
2022 Q1	$0	Buy	+1	New	+$6	﹤0.01%	5275
2021 Q4	–	Sell	-6	Closed	–	–	4708
2021 Q3	$0	Buy	6 +5	+500%	+$36	﹤0.01%	4759
2021 Q2	$0	Hold	1	–	–	﹤0.01%	4623
2021 Q1	$0	Hold	1	–	–	﹤0.01%	4318
2020 Q4	$0	Buy	+1	New	+$8	﹤0.01%	4115
2019 Q3	–	Sell	-1	Closed	–	–	4058
2019 Q2	$0	Sell	1 -199	-100%	-$1.32K	﹤0.01%	4006
2019 Q1	$2K	Buy	200 +199	+19,900%	+$1.55K	﹤0.01%	3419
2018 Q4	$0	Buy	+1	New	+$4	﹤0.01%	3887

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Fidelity Investments's MBOT Position: Q1 2026 in Review

Fidelity Investments increased its Microbot Medical (MBOT) stake by 300% in Q1 2026, buying an estimated $7 and bringing the position to 4 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #5377.

Fidelity Investments first reported a position in MBOT in Q4 2018 and has held it in 16 quarters since. The position peaked at $2K in Q1 2019. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

Fidelity Investments held 4 shares of Microbot Medical worth $10 as of Q1 2026.
Fidelity Investments bought 3 Microbot Medical shares in Q1 2026, an estimated $7.
Microbot Medical made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5377 holding.
Fidelity Investments first reported a position in Microbot Medical in Q4 2018 and has held it in 16 quarters since.
Fidelity Investments's Microbot Medical position peaked at $2K in Q1 2019.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.